Early antiretroviral treatment may preserve key immune responses to HIV: Ragon Institute study findings could pave the way to vaccine development

Instituting combination antiretroviral (ART) treatment at the earliest stages of HIV infection may allow the generation of functional CD8 “killer” T cells and preservation of the CD4 helper T cells that are the virus’s primary